Interaction between economic status and healthy lifestyle in long COVID among Chinese older population: a cross-sectional study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
26 Sep 2024
Historique:
medline: 27 9 2024
pubmed: 27 9 2024
entrez: 26 9 2024
Statut: epublish

Résumé

To estimate the interaction between economic status (ES) and healthy lifestyle in long COVID among Chinese older people infected with SARS-CoV-2. A cross-sectional study based on the Peking University Health Cohort in Anning, Yunnan. All primary health institutions in Anning, Yunnan Province, China, from April to May 2023. A total of 4804 people aged 60 and older infected with SARS-CoV-2 were included in this study. Long COVID was measured by participants' self-reported symptoms using structured questionnaires. ES was measured by last-month personal income, and participants' ES was defined as low if their income was below the per capita monthly income of local residents. Lifestyle score was equal to the number of healthy behaviours (including smoking, drinking, weight, exercise and diet) and grouped using the median score as the cut-off point. Univariate and multivariate logistic models were employed to estimate the association of ES with long COVID. Interaction between ES and lifestyle in long COVID was assessed by multiplicative interaction term. We enrolled a total of 4804 participants infected with SARS-CoV-2, of whom 57.3% (2754 of 4804) had at least one long COVID symptom. Fatigue (1546, 56.1%), cough (1263, 45.9%) and muscle pain (880, 32.0%) were the top three common symptoms. Patients with low ES had a 48% (adjusted OR: 1.48; 95% CI 1.22, 1.82) increased risk of long COVID. A significant interaction was observed between ES and lifestyle (p value for interaction <0.001) in long COVID. The interaction between ES and healthy lifestyle in long COVID was prominent. Comprehensive strengthened economic support for patients recovering from COVID-19, especially for those with low healthy lifestyle, should be implemented to prevent and manage long COVID symptoms.

Identifiants

pubmed: 39327050
pii: bmjopen-2023-082314
doi: 10.1136/bmjopen-2023-082314
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e082314

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Yaping Wang (Y)

Department of Epidemiology and Biostatistics, Peking University, Beijing, China.
Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.

Manchang Li (M)

Anning First People's Hospital, Kunming University of Science and Technology, Kunming, China.

Bingkun Zhang (B)

Anning First People's Hospital, Kunming University of Science and Technology, Kunming, China.

Yue Feng (Y)

Anning First People's Hospital, Kunming University of Science and Technology, Kunming, China.

Yinghui Yu (Y)

Anning First People's Hospital, Kunming University of Science and Technology, Kunming, China.

Ling Guo (L)

Anning First People's Hospital, Kunming University of Science and Technology, Kunming, China.

Min Du (M)

Department of Epidemiology and Biostatistics, Peking University, Beijing, China.
Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.

Wenxin Yan (W)

Department of Epidemiology and Biostatistics, Peking University, Beijing, China.
Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.

Qiao Liu (Q)

Department of Epidemiology and Biostatistics, Peking University, Beijing, China.
Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.

Chenyuan Qin (C)

Department of Epidemiology and Biostatistics, Peking University, Beijing, China.
Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.

Jie Deng (J)

Department of Epidemiology and Biostatistics, Peking University, Beijing, China.
Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.

Chao Song (C)

Anning First People's Hospital, Kunming University of Science and Technology, Kunming, China jueliu@bjmu.edu.cn chaosong_1@sina.com.

Jue Liu (J)

Department of Epidemiology and Biostatistics, Peking University, Beijing, China jueliu@bjmu.edu.cn chaosong_1@sina.com.
Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH